Previous Article | Next Article ![]()
J. Bacteriol., Nov 1997, 6602-6608, Vol 179, No. 21
A Rietsch, P Bessette, G Georgiou and J Beckwith
The Escherichia coli periplasmic protein DsbC is active both in vivo and in
vitro as a protein disulfide isomerase. For DsbC to attack incorrectly
formed disulfide bonds in substrate proteins, its two active-site cysteines
should be in the reduced form. Here we present evidence that, in wild-type
cells, these two cysteines are reduced. Further, we show that a pathway
involving the cytoplasmic proteins thioredoxin reductase and thioredoxin
and the cytoplasmic membrane protein DsbD is responsible for the reduction
of these cysteines. Thus, reducing potential is passed from cytoplasmic
electron donors through the cytoplasmic membrane to DsbC. This pathway does
not appear to utilize the cytoplasmic glutathione-glutaredoxin pathway. The
redox state of the active-site cysteines of DsbC correlates quite closely
with its ability to assist in the folding of proteins with multiple
disulfide bonds. Analysis of the activity of mutant forms of DsbC in which
either or both of these cysteines have been altered further supports the
role of DsbC as a disulfide bond isomerase.
Copyright © 1997, American Society for Microbiology
Reduction of the periplasmic disulfide bond isomerase, DsbC, occurs by passage of electrons from cytoplasmic thioredoxin
Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.
This article has been cited by other articles:
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |